What Is Basel Medical Group Ltd (BMGL) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Basel Medical Group Ltd's intrinsic value is estimated at $11.13, suggesting a +73.5% average upside from the current price of $6.41. While 8 models see room for appreciation, model agreement is not unanimous as 3 models flag potential overvaluation. Model dispersion is worth noting: First Chicago targets $20.21 (+215.1%), versus Dynamic NAV at $0.01 (-99.9%). This +315.0% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About BMGL?
12 of 13 models are currently active for BMGL. Of these, 9 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates BMGL's intrinsic value at $16.74, implying +161.0% upside from the current price. See which stocks rank higher →
How Does BMGL Rank in Services-Offices & Clinics of Doctors of Medicine?
Among 8 Services-Offices & Clinics of Doctors of Medicine stocks, BMGL ranks #2 by Quality of Company score. CirclFi's QOC score of 8.0/10 evaluates 32 fundamental signals. A score of 8.0 places BMGL in the top tier.
Basel Medical Group Ltd operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is BMGL a Value Trap?
The Value Trap algorithm is not active for BMGL. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Basel Medical Group Ltd. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Basel Medical Group Ltd earns a quality score of 8.0/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +315.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BMGL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BMGL's 12 active models, average confidence is 29%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →